en

PRODUCT DETAIL

Levosimendan Zentiva

Code 9996D
MA number 41/0074/22-S
Product Form: con inf 1x5 ml/12,5 mg (liek.skl.inj.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 41 - CARDIACA
ATC:
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CX Other cardiac stimulants
C01CX08 Levosimendan
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 30.03.2022
Validity: 30.03.2027
Pediatric warnings: Yes
SPC: SPC_Levosimendan Zentiva_con inf_08_2022.pdf  
PIL: PIL_Levosimendan Zentiva_con inf_08_2022.pdf  
Safety feature Yes
Data update: 31.03.2022
eu-flag.png sk-flag.png